Benjamin Perry
Fondatore presso MPC Therapeutics SA
Profilo
Benjamin Perry has founded MPC Therapeutics SA in 2018, where he holds the title of Director.
Currently, he is working as a Principal at Medicxi Ventures (Jersey) Ltd.
since 2022.
Mr. Perry has a doctorate degree from Imperial College London, which he received in 2002, and a graduate degree from Swansea University, which he received in 1999.
Posizioni attive di Benjamin Perry
Società | Posizione | Inizio |
---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investitore di Private Equity | 01/11/2022 |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology MPC Therapeutics SA is a company based in Plan-les-Ouates, Switzerland. The Swiss company was founded in 2018 by Benjamin Perry and has been led by CEO Raphael Martinou since its inception. | Fondatore | 01/01/2018 |
Formazione di Benjamin Perry
Imperial College London | Doctorate Degree |
Swansea University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology MPC Therapeutics SA is a company based in Plan-les-Ouates, Switzerland. The Swiss company was founded in 2018 by Benjamin Perry and has been led by CEO Raphael Martinou since its inception. | Health Technology |
- Borsa valori
- Insiders
- Benjamin Perry